The ESMO 2018 Congress is fast approaching (Twitter hashtag: #ESMO18) and BSB will be in Munich diligently providing on-site coverage for subscribers.
Over 2000 abstracts will be presented on the latest cancer immunotherapy research, biomarkers and translational research.
We’ll have plenty to write about, plus we hope to record some interviews that we may excerpt on the Novel Targets Podcast, so stay tuned for that too.
In our third preview, we highlight what we think are key abstracts to watch out for in Munich outside of the late breakers (those are covered here) in terms of how they advance our thinking and move the field forward, or could impact clinical practice.
Here we go – ESMO18 Preview 3 Top 10 Oral Abstracts to watch out for…